Delivery Order SPE2DH25D0001-SPE2D425F506D
- Not listed
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order for METLYTE 8 PANEL products valued at $3,570.75 on June 26, 2025, with an ultimate completion date of June 30, 2025. This fixed-price contract with economic price adjustment was awarded without a set-aside designation, indicating full and open competition. The contract is being performed in North Chicago, Illinois, and is funded by the Defense Medical Supply Chain, a defense-oriented federal...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order for METLYTE 8 PANEL products valued at $2,461.00 on August 11, 2025, with an ultimate completion date of August 13, 2025. The contract utilizes fixed price pricing with economic price adjustment terms and will be performed in North Chicago, Illinois. This delivery order was awarded without a set-aside designation, indicating full and open competition. The funding source is the Defense Medical Supply...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $3,691.50 by the Medical Supply Chain, a Defense agency function, on October 8, 2025. The contract, identified as METLYTE 8 PANEL, represents a fixed-price delivery order with economic price adjustment provisions and is scheduled for completion by October 10, 2025. The work will be performed in North Chicago, Illinois, where Abbott maintains its headquarters and point-of-care division....
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $1,230.50 on November 3, 2025, for the METLYTE 8 Panel with an ultimate completion date of November 5, 2025. This fixed-price delivery order with economic price adjustment was issued by the Defense Logistics Agency Medical Supply Chain, a defense-focused federal agency responsible for medical supply procurement. The contract was awarded without a set-aside designation under full and open...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a fixed-price delivery order valued at $1,230.50 on October 30, 2025, for the METLYTE 8 PANEL, with an ultimate completion date of November 3, 2025. The contract was issued by the Defense Logistics Agency's Medical Supply Chain division without a set-aside designation and will be performed in North Chicago, Illinois, where Abbott maintains its headquarters. The pricing structure includes economic price adjustment...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $3,691.50 for the supply of METLYTE 8 Panel products under a fixed-price contract with economic price adjustment provisions. The award, issued on September 11, 2025, with an ultimate completion date of September 15, 2025, represents a non-competitive procurement without set-aside designation. The work will be performed at Abbott's facility in North Chicago, Illinois, and is funded...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order contract by the Defense-affiliated Medical Supply Chain agency on October 14, 2025, with an ultimate completion date of October 16, 2025. The contract, valued at $1,938.56, utilizes fixed-price pricing with economic price adjustment terms and will be performed in North Chicago, Illinois. This delivery order was awarded without a set-aside designation, indicating full and open competition. The...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $14,191.30 on August 20, 2025, by the Medical Supply Chain, a defense-focused federal agency. This firm fixed-price contract, which is scheduled for completion by August 25, 2025, was awarded without a set-aside designation, indicating full and open competition. The delivery order pertains to an analytical piccolo xpress rapid glycemic display multilayer deployment kit, which aligns with...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $8,845.53 by the Defense Medical Supply Chain on August 20, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price delivery order, issued without a set-aside designation indicating full and open competition, is for medical diagnostic equipment and supplies to be delivered to North Chicago, Illinois. The award represents a task order under Abbott's existing Blanket...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $8,845.53 by the Defense Department's Medical Supply Chain on September 2, 2025, with an ultimate completion date of September 5, 2025. This firm fixed-price delivery order, which carries no set-aside designation and indicates full and open competition, represents a task order against a larger Blanket Purchase Agreement vehicle. Based on Abbott's established federal contracting history,...
- SPE2DH25D0001Indefinite Delivery Contract
- SPE2DH25D0001-SPE2D425F506DDelivery Order
Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $1,845.75 for the METLYTE 8 Panel on August 6, 2025, with an ultimate completion date of August 8, 2025. This fixed-price delivery order with economic price adjustment was issued without a set-aside designation, indicating full and open competition. The contract is being performed in North Chicago, Illinois, and is funded by the Defense Medical Supply Chain, a defense-focused federal agency. The METLYTE 8 Panel represents a point-of-care testing product, consistent with Abbott's established role as a primary supplier of medical diagnostic equipment and clinical testing technologies to federal agencies. This delivery order likely represents a task order issued against one of Abbott's existing Blanket Purchase Agreements or Indefinite Delivery Vehicles, such as those established under GSA Schedule contracts for In-Vitro Diagnostics and Laboratory testing supplies. Abbott's extensive history of federal contracting with the Department of Veterans Affairs and defense agencies underscores the company's established position as a critical supplier of diagnostic and point-of-care testing solutions to the federal healthcare system. The brief performance window reflects the expedited nature of the delivery order, typical of calls against existing contract vehicles established to meet urgent federal procurement needs for essential medical testing capabilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 8/6/25 |